The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,844,463 in first-year total cost, median $225,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 SBIB-Q (11)]2
- Special Emphasis Panel[ZRG1 CVRS-C (10)]1
- Special Emphasis Panel[ZRG1 ETTN-C (10)]1
- Special Emphasis Panel[ZRG1 ETTN-G (12)]1
- Special Emphasis Panel[ZRG1 IMST-M (13)]1
Most frequent institutions
- NOVERATECH, LLC2
- VISIONQUEST BIOMEDICAL, LLC2
- AVENTUSOFT, LLC1
- LASMED, LLC1
- MEDCHEM PARTNERS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Measurement of Retinal Nerves and Blood Vessels as Markers for Type 1 Diabetes1R44DK113932-01 | MUJAT, MIRCEA | PHYSICAL SCIENCES, INC, MA | $230,823 | ZRG1 |
| 2017 | Innovation for the earlydetection, diagnosis, and quantification of diabetic cardiomyopathy.1R43DK113890-01A1 | KALE, KAUSTUBH | AVENTUSOFT, LLC, FL | $225,000 | ZRG1 |
| 2016 | Quantitative Biomarkers of T1D Peripheral Neuropathy using Functional Imaging2R44DK104578-02 | BURGE, MARK RSOLIZ, PETER N | VISIONQUEST BIOMEDICAL, LLC, NM | $794,688 | ZRG1 |
| 2016 | A flowable microporous biomaterial as a low cost, high efficacy diabetic chronic ulcer treatment1R43DK109843-01 | WEAVER, WESTBROOK M | TEMPO THERAPEUTICS, INC., CA | $224,999 | ZRG1 |
| 2016 | Pressure and Temperature Monitoring and Regulating Insole1R43DK109858-01A1 | HIRSCHMAN, GORDON BYAVUZ, METIN | VIVONICS, INC., MA | $224,974 | ZRG1 |
| 2015 | A new biomarker for diabetic foot ulcers1R43DK104625-01 | CHIEN, SUFAN | NOVERATECH, LLC, KY | $280,702 | ZRG1 |
| 2015 | A new technique for diabetic foot ulcers1R43DK105692-01 | CHIEN, SUFAN | NOVERATECH, LLC, KY | $275,457 | ZRG1 |
| 2015 | Depletion of heat sensitive cutaneous nociceptors by infrared light1R43DK105687-01 | NEMENOV, MIKHAIL I. | LASMED, LLC, CA | $225,000 | ZRG1 |
| 2015 | Quantitative biomarkers of T1D peripheral neuropathy using functional imaging1R43DK104578-01A1 | BURGE, MARK RSOLIZ, PETER N | VISIONQUEST BIOMEDICAL, LLC, NM | $211,067 | ZRG1 |
| 2015 | Drug containing hydrogels which release nitric oxide for diabetic wound healing1R43DK105603-01 | LAZAROVA, TSVETELINA IVANONOVAORGILL, DENNIS P | MEDCHEM PARTNERS, LLC, MA | $151,753 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.